Compare VREX & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VREX | KMDA |
|---|---|---|
| Founded | 2016 | 1990 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 580.6M | 488.6M |
| IPO Year | 2016 | 2013 |
| Metric | VREX | KMDA |
|---|---|---|
| Price | $11.97 | $8.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $16.67 | $14.00 |
| AVG Volume (30 Days) | ★ 202.1K | 54.4K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 3.03% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $811,000,000.00 | N/A |
| Revenue This Year | $5.35 | $13.94 |
| Revenue Next Year | $3.88 | $9.84 |
| P/E Ratio | $232.40 | ★ $24.59 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.76 | $6.35 |
| 52 Week High | $14.57 | $9.35 |
| Indicator | VREX | KMDA |
|---|---|---|
| Relative Strength Index (RSI) | 61.43 | 51.98 |
| Support Level | $11.43 | $8.38 |
| Resistance Level | $12.61 | $8.88 |
| Average True Range (ATR) | 0.35 | 0.20 |
| MACD | 0.22 | 0.02 |
| Stochastic Oscillator | 89.06 | 85.71 |
Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.